PBD Biotech

company

About

PBD Biotech specialises in novel phage-based diagnostics for the veterinary, agriculture and human health sectors

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.30M
Industries
Agriculture,AgTech,Biotechnology,Medical,Medical Device,Veterinary
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

PBD Biotech has developed the only rapid, sensitive test to detect live mycobacteria, which are responsible for bovine TB and Johne’s Disease, both economically disastrous.

Trials have demonstrated the effectiveness of Actiphage, which can detect mycobacteria at low levels in blood or milk within six hours. The test has applications in quality control of dairy products, and could revolutionise the way bovine TB and other livestock diseases are identified and managed.

Since the company established, it has gained funding, UK government approval for exceptional private use, proven efficacy in the field, opened an office in Canada and trials are currently underway on farms, in hospital and with national institutions around the world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.30M
PBD Biotech has raised a total of $2.30M in funding over 2 rounds. Their latest funding was raised on Mar 30, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 30, 2021 Series Unknown $2.30M 2 Mercia Fund Managers
Foresight Group
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
PBD Biotech is funded by 2 investors. Mercia Fund Managers and Foresight Group are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Yes Series Unknown
Foresight Group Yes Series Unknown